Kelly Financial Services LLC Abbott Laboratories Transaction History

Kelly Financial Services LLC

$325 Million
Q3 2025

A detailed history of Kelly Financial Services LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kelly Financial Services LLC holds 1,888 shares of ABT stock, worth $245,496. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,888

Previous 1,787 5.65%

Holding current value

$245,496

Previous $243,000 3.7%

% of portfolio

0.08%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	BUY	$120.51 - $136.62 $12,171 - $13,798	101 Added 5.65%	1,888 $252,000
Q2 2025 Jul 17, 2025	BUY	$123.95 - $138.08 $19,584 - $21,816	158 Added 9.7%	1,787 $243,000
Q1 2025 Apr 15, 2025	BUY	$111.1 - $140.22 $180,981 - $228,418	1,629 New	1,629 $216,000
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $21,959 - $24,511	218 Added 23.12%	1,161 $120,000
Q1 2024 Jul 17, 2024	BUY	$109.52 - $120.96 $11,718 - $12,942	107 Added 12.8%	943 $107,000

Q4 2023 Jul 17, 2024	BUY	$90.19 - $110.4 $12,446 - $15,235	138 Added 19.77%	836 $92 Million
Q3 2023 Jul 17, 2024	SELL	$95.53 - $114.62 $3,630 - $4,355	-38 Reduced 5.16%	698 $67.6 Million
Q2 2023 Jul 17, 2024	BUY	$100.78 - $112.29 $14,411 - $16,057	143 Added 24.11%	736 $80.2 Million
Q1 2023 Jul 17, 2024	BUY	$96.86 - $114.01 $5,714 - $6,726	59 Added 11.05%	593 $60 Million
Q4 2022 Jul 17, 2024	BUY	$95.06 - $111.52 $190 - $223	2 Added 0.38%	534 $58.6 Million
Q3 2022 Jul 17, 2024	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.19%	532 $51.5 Million
Q2 2022 Jul 17, 2024	BUY	$102.07 - $123.37 $102 - $123	1 Added 0.19%	531 $57.7 Million
Q1 2022 Jul 17, 2024	SELL	$114.02 - $139.04 $11,287 - $13,764	-99 Reduced 15.74%	530 $62.7 Million
Q4 2021 Jul 17, 2024	BUY	$115.53 - $141.46 $115 - $141	1 Added 0.16%	629 $88.5 Million
Q3 2021 Jul 17, 2024	SELL	$116.66 - $129.06 $8.41 Million - $9.3 Million	-72,083 Reduced 99.14%	628 $74.2 Million
Q2 2021 Jul 17, 2024	BUY	$105.79 - $124.53 $7.63 Million - $8.98 Million	72,128 Added 12371.87%	72,711 $627,000
Q1 2021 Jul 17, 2024	BUY	$108.84 - $128.23 $108 - $128	1 Added 0.17%	583 $69.9 Million
Q4 2020 Jul 17, 2024	SELL	$105.0 - $114.42 $2,100 - $2,288	-20 Reduced 3.32%	582 $63.7 Million
Q3 2020 Jul 17, 2024	BUY	$91.64 - $111.29 $91 - $111	1 Added 0.17%	602 $65.6 Million
Q2 2020 Jul 17, 2024	BUY	$76.57 - $98.0 $3,139 - $4,018	41 Added 7.32%	601 $55 Million
Q1 2020 Jul 17, 2024	BUY	$62.82 - $91.86 $6,156 - $9,002	98 Added 21.21%	560 $44.2 Million
Q2 2019 Jul 17, 2024	BUY	$72.88 - $85.0 $72 - $85	1 Added 0.22%	462 $38.8 Million
Q1 2019 Jul 17, 2024	BUY	$66.22 - $80.06 $30,527 - $36,907	461 New	461 $36.9 Million

Others Institutions Holding ABT

# of Institutions

3,651

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Account

Kelly Financial Services LLC Abbott Laboratories Transaction History